| 臺大學術典藏 |
2021-07-22T01:17:01Z |
Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study
|
LI-TA KENG; MENG-RUI LEE; Chong-Jen Yu; Jann-Yuan Wang; Hung-Ling Huang; Hsu-Liang Chang; Chau-Chyun Sheu; Pin-Kuei Fu; Inn-Wen Chong; Jin-Yuan Shih |
| 臺大學術典藏 |
2021-07-21T23:21:30Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
SHANG-GIN WU; WEI-YU LIAO; KANG-YI SU; SUNG-LIANG YU; Huang, Yen Lin; CHONG-JEN YU; Chih-Hsin Yang, James; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-07-21T23:21:17Z |
Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study
|
MENG-RUI LEE; Huang, Hung Ling; LI-TA KENG; Chang, Hsu Liang; Sheu, Chau Chyun; Fu, Pin Kuei; JANN-YUAN WANG; Chong, Inn Wen; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2021-07-15T05:32:16Z |
Dual energy CT image prediction on primary tumor of lung cancer for nodal metastasis using deep learning
|
Wang, You Wei; Chen, Chii Jen; Huang, Hsu Cheng; Wang, Teh Chen; HSIN-MING CHEN; JIN-YUAN SHIH; JIN-SHING CHEN; YU-SEN HUANG; YEUN-CHUNG CHANG; RUEY-FENG CHANG |
| 臺大學術典藏 |
2021-07-15T05:31:52Z |
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
|
Lin, Chia Yi; Huang, Kuo Yen; Lin, Yi Chun; Yang, Shuenn Chen; Chung, Wei Chia; YIH-LEONG CHANG; JIN-YUAN SHIH; CHAO-CHI HO; Lin, Chih An; Shih, Chih Chun; Chang, Ya Hsuan; Kao, Shih Han; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-07-15T05:31:52Z |
Efficacy and safety of cone-beam computed tomography-derived augmented fluoroscopy combined with endobronchial ultrasound in peripheral pulmonary lesions
|
KAI-LUN YU; SHUN-MAO YANG; Ko, Huan Jang; Tsai, Hui Yu; JEN-CHANG KO; Lin, Ching Kai; CHAO-CHI HO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-21T11:40:32Z |
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer
|
CHIA-LIN HSU; TZU-HSIU TSAI; CHUN-KAI HUANG; Yang, Ching Yao; WEI-YU LIAO; CHAO-CHI HO; SHENG-YUAN RUAN; Chen, Kuan Yu; JIN-YUAN SHIH; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-05-02T03:49:16Z |
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
|
Lin C.-C.;Huang Y.-K.;Cho C.-F.;Lin Y.-S.;Lo C.-C.;Kuo T.-T.;Tseng G.-C.;Cheng W.-C.;Chang W.-C.;Hsiao T.-H.;Lai L.-C.;Jin-Yuan Shih;Liu Y.-H.;Clifford Chao K.S.;Hsu J.L.;Lee P.-C.;Sun X.;Hung M.-C.;Sher Y.-P.; Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Lai L.-C.; JIN-YUAN SHIH; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P. |
| 臺大學術典藏 |
2021-05-02T03:49:15Z |
Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life
|
Hsieh C.-C.;Ho C.-C.;Lin Z.-Z.;Yu C.-J.;Jow G.-M.;Huang F.-Y.;Jin-Yuan Shih;Hsiao F.-H.; Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; Yu C.-J.; Jow G.-M.; Huang F.-Y.; JIN-YUAN SHIH; Hsiao F.-H. |
| 臺大學術典藏 |
2021-05-02T03:49:15Z |
Detecting small pulmonary nodules with spiral ultrashort echo time sequences in 1.5?T MRI
|
Huang Y.-S.;Niisato E.;Su M.-Y.M.;Benkert T.;Hsu H.-H.;Jin-Yuan Shih;Chen J.-S.;Chang Y.-C.; Huang Y.-S.; Niisato E.; Su M.-Y.M.; Benkert T.; Hsu H.-H.; JIN-YUAN SHIH; Chen J.-S.; Chang Y.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:15Z |
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
|
Wu S.-G.;Yu C.-J.;Yang J.C.-H.;Jin-Yuan Shih; Wu S.-G.; Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
|
Wu S.-G.;Chiang C.-L.;Liu C.-Y.;Wang C.-C.;Su P.-L.;Hsia T.-C.;Jin-Yuan Shih;Chang G.-C.; Wu S.-G.; Chiang C.-L.; Liu C.-Y.; Wang C.-C.; Su P.-L.; Hsia T.-C.; JIN-YUAN SHIH; Chang G.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
Does pemetrexed work in targetable, nonsquamous non-small-cell lung cancer? A narrative review
|
Jin-Yuan Shih;Inoue A.;Cheng R.;Varea R.;Kim S.-W.; JIN-YUAN SHIH; Inoue A.; Cheng R.; Varea R.; Kim S.-W. |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
Sustained partial response to afatinib in a patient with lung adenocarcinoma harboring HER2V659E mutation
|
Chang L.-K.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:14Z |
Successful management of a ROS1-rearranged pulmonary pleomorphic carcinoma using serial tyrosine kinase inhibitors
|
Wu C.-W.;Yang C.-Y.;Chang Y.-L.;Jin-Yuan Shih; Wu C.-W.; Yang C.-Y.; Chang Y.-L.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:13Z |
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY
|
Nishio M.;Seto T.;Reck M.;Garon E.B.;Chiu C.-H.;Yoh K.;Imamura F.;Park K.;Jin-Yuan Shih;Visseren-Grul C.;Frimodt-Moller B.;Zimmermann A.;Homma G.;Enatsu S.;Nakagawa K.;Relay Study Investigators; Nishio M.; Seto T.; Reck M.; Garon E.B.; Chiu C.-H.; Yoh K.; Imamura F.; Park K.; JIN-YUAN SHIH; Visseren-Grul C.; Frimodt-Moller B.; Zimmermann A.; Homma G.; Enatsu S.; Nakagawa K.; RELAY Study Investigators |
| 臺大學術典藏 |
2021-05-02T03:49:13Z |
miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-�eB Pathway
|
Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Wang H.-Y.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Wang H.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-02T03:49:13Z |
Effect of �]-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs
|
Chang C.-H.;Lee C.-H.;Ko J.-C.;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Jin-Yuan Shih;Yu C.-J.; Chang C.-H.; Lee C.-H.; Ko J.-C.; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
|
Lu S.; JIN-YUAN SHIH; Jang T.-W.; Liam C.-K.; Yu Y. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang G.-C.; Lam D.C.-L.; Tsai C.-M.; Chen Y.-M.; JIN-YUAN SHIH; Aggarwal S.; Wang S.; Kim S.-W.; Kim Y.-C.; Wahid I.; Li R.; Lim D.W.-T.; Sriuranpong V.; Chan R.T.-T.; Lorence R.M.; Carriere P.; Raabe C.; Cseh A.; Park K. |
| 臺大學術典藏 |
2021-05-02T03:49:11Z |
Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel
|
Huang J.-W.; Kuo C.-H.; Kuo H.-C.; JIN-YUAN SHIH; Tsai T.-W.; Chang L.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:11Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; JIN-YUAN SHIH; Chang Y.-L.; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:10Z |
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer
|
Hsu C.-L.; Tsai T.-H.; Huang C.-K.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Ruan S.-Y.; Chen K.-Y.; JIN-YUAN SHIH; Yang P.-C. |
| 臺大學術典藏 |
2021-05-02T03:49:10Z |
Differences in Fatty Acid Oxidation between Nab-Paclitaxel- And Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics
|
Huang J.-W.; Kuo C.-H.; Kuo H.-C.; JIN-YUAN SHIH; Tsai T.-W.; Chang L.-C. |
